We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Scotts Miracle-Gro Company (SMG - Free Report) is currently a Zacks Rank #5 (Strong Sell) with an overall VGM Score of an F – never a combination you want to see.
SMG is a leading producer and marketer of branded garden and consumer lawn products. The company’s product portfolio includes Scotts, Miracle-Gro, and Ortho. In addition, the company markets the herbicide Roundup.
Share Performance
SMG shares have been stuck in a deep downtrend for the majority of the last year, with shares losing more than half of their value and extensively underperforming the S&P 500.
Image Source: Zacks Investment Research
This price action of SMG shares tells us one clear thing – sellers have been in complete control, pushing bulls out of the arena.
Valuation
In addition to disheartening share performance, the company’s shares could be considered overvalued, further displayed by its Style Score of an F for Value. The company’s forward earnings multiple resides at 17.6X, representing a substantial 154% premium relative to its Zacks Sector.
Image Source: Zacks Investment Research
Growth Estimates
Analysts have extensively lowered their earnings outlook across all timeframes over the last 60 days, a reason the company is ranked as a Zacks Rank #5 (Strong Sell).
Image Source: Zacks Investment Research
For the upcoming quarter, the Zacks Consensus EPS Estimate resides at $1.70, penciling in a nearly 60% drop in quarterly earnings year-over-year.
In addition, current fiscal year earnings are projected to plummet a double-digit 50%.
SMG’s top-line appears to be in rough shape as well; the $1.2 billion quarterly revenue estimate for the upcoming quarter pencils in a double-digit 25% year-over-year decline.
Furthermore, the annual revenue estimate of $4.1 billion reflects a disheartening 16% drop in sales from the previous year.
Bottom Line
SMG shares have been the victim of a deep double-digit valuation slash over the last year, with sellers remaining in complete control. This adverse price action, paired with overwhelmingly negative estimate revisions and elevated valuation levels, paints a grim picture for the company in the short term.
The company is a Zacks Rank #5 (Strong Sell) and a stock that investors will be better off staying away from for now.
Instead, investors should pivot to stocks that either carry a Zacks Rank #1 (Strong Buy) or Zacks Rank #2 (Buy) – the odds of reaping considerable gains are much higher within the companies that carry these ranks.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
Bear of the Day: Scotts Miracle-Gro
The Scotts Miracle-Gro Company (SMG - Free Report) is currently a Zacks Rank #5 (Strong Sell) with an overall VGM Score of an F – never a combination you want to see.
SMG is a leading producer and marketer of branded garden and consumer lawn products. The company’s product portfolio includes Scotts, Miracle-Gro, and Ortho. In addition, the company markets the herbicide Roundup.
Share Performance
SMG shares have been stuck in a deep downtrend for the majority of the last year, with shares losing more than half of their value and extensively underperforming the S&P 500.
Image Source: Zacks Investment Research
This price action of SMG shares tells us one clear thing – sellers have been in complete control, pushing bulls out of the arena.
Valuation
In addition to disheartening share performance, the company’s shares could be considered overvalued, further displayed by its Style Score of an F for Value. The company’s forward earnings multiple resides at 17.6X, representing a substantial 154% premium relative to its Zacks Sector.
Image Source: Zacks Investment Research
Growth Estimates
Analysts have extensively lowered their earnings outlook across all timeframes over the last 60 days, a reason the company is ranked as a Zacks Rank #5 (Strong Sell).
Image Source: Zacks Investment Research
For the upcoming quarter, the Zacks Consensus EPS Estimate resides at $1.70, penciling in a nearly 60% drop in quarterly earnings year-over-year.
In addition, current fiscal year earnings are projected to plummet a double-digit 50%.
SMG’s top-line appears to be in rough shape as well; the $1.2 billion quarterly revenue estimate for the upcoming quarter pencils in a double-digit 25% year-over-year decline.
Furthermore, the annual revenue estimate of $4.1 billion reflects a disheartening 16% drop in sales from the previous year.
Bottom Line
SMG shares have been the victim of a deep double-digit valuation slash over the last year, with sellers remaining in complete control. This adverse price action, paired with overwhelmingly negative estimate revisions and elevated valuation levels, paints a grim picture for the company in the short term.
The company is a Zacks Rank #5 (Strong Sell) and a stock that investors will be better off staying away from for now.
Instead, investors should pivot to stocks that either carry a Zacks Rank #1 (Strong Buy) or Zacks Rank #2 (Buy) – the odds of reaping considerable gains are much higher within the companies that carry these ranks.